The effect of three major co-morbidities on quality of life and outcome of patients with heart failure with reduced ejection fraction.

In stable advanced HFrEF patients, co-morbidities are not associated with impaired QoL, but negatively affect the prognosis both directly and indirectly through lower level of HF pharmacotherapy and increased myocardial stress and injury.